Results 201 to 210 of about 1,254,591 (276)

New pharmacological agents and emerging therapeutic targets for painful diabetic neuropathy. [PDF]

Front Endocrinol (Lausanne)
Panou T, Papanas N, Kempler P.
europepmc   +1 more source

Disentangling the effect of brain insulin resistance on brain health (BIR‐BrainHealth): Rationale and study protocol

Diabetic Medicine, EarlyView.
Abstract Aims Insulin signalling in the brain is crucial for systemic metabolic regulation and cognitive function. In some individuals, these effects are reduced, a phenomenon referred to as brain insulin resistance (BIR). This condition may contribute to the elevated risk of cognitive decline and dementia in diabetes, yet its prevalence, mechanisms ...
Sabrina Wangler, Peter Sørensen, Konni Kass, Nicole Jaqueline Jensen, Mark Bitsch Vestergaard, Julia Hummel, Ronja Völk, Julie Christine Antvorskov, Flemming Pociot, Jørgen Rungby, Martin Heni, Henrik Bo Wiberg Larsson   +11 more
wiley   +1 more source

Diabetic Neuropathy: From Etiopathogenesis to Integrative Therapeutic Strategies with Traditional Chinese Medicine. [PDF]

Int J Gen Med
Hu B, Aruna, Bao S, Bao G, Aowuliji.
europepmc   +1 more source

Impact of diabetes mellitus on the menopausal experience: A scoping review

Diabetic Medicine, EarlyView.
Abstract Aims To identify, appraise and synthesise the current evidence relating to symptoms, experiences, management and impact of menopause on QoL among women with type 1 diabetes (T1DM) or type 2 diabetes (T2DM) and to identify evidence gaps. Methods We conducted a scoping review guided by Arksey and O'Mally's framework by searching CINAHL, MEDLINE,
Rachel Black, Felicity Hasson, Lisa King, Mark Davies, Deborah Muldrew, Paul Slater, Jenny Johnston, Dawn Adams, Rhonda Murphy, George Kernohan, Vivien Coates   +10 more
wiley   +1 more source

Dermal fibroblast mitochondrial profiles in painful diabetic neuropathy. [PDF]

Diabetologia
Bentzen JMM, Brask-Thomsen PK, Krogsbæk M, Hu X, Nyengaard JR, Gylfadottir SS, Karlsson P, Finnerup NB, Olsen RKJ, Nochi Z.   +9 more
europepmc   +1 more source

The effect of telemonitoring on quality of life in people with insulin‐treated type 2 diabetes: A secondary analysis of a randomised controlled trial

Diabetic Medicine, EarlyView.
Abstract Aims Telemonitoring in type 2 diabetes (T2D) care has demonstrated positive trends in terms of glycaemic control. However, evidence regarding its impact on patient‐reported outcomes, such as general and diabetes‐specific quality of life (QoL), remains inconclusive.
Rúni Knoph, Jannie Toft Damsgaard Nørlev, Thomas Kronborg, Peter Vestergaard, Morten Hasselstrøm Jensen, Stine Hangaard   +5 more
wiley   +1 more source

Sensory Ataxia Mimicking Diabetic Neuropathy in a Long-Term Metformin User: A Case Report From Korea. [PDF]

Cureus
Park J.
europepmc   +1 more source

DiaActive protocol: A randomized controlled trial of cognitive‐motor multicomponent exercise to reduce fall rate in older adults with diabetes

Diabetic Medicine, EarlyView.
Abstract Introduction Older adults with diabetes have an increased risk of falls due to neuropathy, impaired bone health and cardiovascular disease, resulting in significant morbidity and mortality. Conventional fall‐prevention programmes primarily target strength and balance, while cognitive‐motor integration, essential for safe mobility in complex ...
Aksayan Arunanthy Mahalingasivam, Asger Ahlmann Bech, Peter Vestergaard, Martin Grønbech Jørgensen, Nicklas Højgaard‐Hessellund Rasmussen   +4 more
wiley   +1 more source

The role of clinical laboratory parameters in diabetic neuropathy: correlations and recent advances. [PDF]

Front Endocrinol (Lausanne)
Guo R, Lou P, Li M, Tian M, Gao L, Ma H, Liu Y, Jiang X.   +7 more
europepmc   +1 more source

Dysglycaemia and Autonomic Dysfunction: The Diabetes Prevention Program Outcomes Study

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim Limited data on the link between various measures of glycemia and metabolism and autonomic dysfunction exist. We assessed the association of fasting plasma glucose [FPG], glycated haemoglobin [HbA1C], fasting insulin, and HOMA‐IR and cardiac autonomic function measures separately for men and women in the Diabetes Prevention Program ...
Justin B. Echouffo‐Tcheugui, Xun Liu, Elsayed Z. Soliman, Xavier Pi‐Sunyer, Sherita H. Golden, Sam Dagogo‐Jack, Neil H. White, Matthew Budoff, Uzoma Ibebuogu, Christine Darwin, William C. Knowler, Marinella Temprosa, on behalf of the DPP Research Group   +12 more
wiley   +1 more source